ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,919 | -12.8% | 12,808 | +0.2% | 0.05% | -14.5% |
Q2 2023 | $306,105 | +26.5% | 12,781 | -0.6% | 0.06% | +24.0% |
Q1 2023 | $242,025 | +18.3% | 12,860 | +0.1% | 0.05% | +16.3% |
Q4 2022 | $204,508 | -23.4% | 12,846 | -21.4% | 0.04% | -35.8% |
Q3 2022 | $267,000 | +16.1% | 16,346 | 0.0% | 0.07% | +24.1% |
Q2 2022 | $230,000 | -40.1% | 16,346 | +3.2% | 0.05% | -28.9% |
Q1 2022 | $384,000 | +10.7% | 15,846 | +6.7% | 0.08% | +16.9% |
Q4 2021 | $347,000 | -25.4% | 14,846 | -47.0% | 0.06% | -31.6% |
Q3 2021 | $465,000 | -24.4% | 28,000 | +11.1% | 0.10% | -24.6% |
Q2 2021 | $615,000 | -5.4% | 25,200 | 0.0% | 0.13% | -10.6% |
Q1 2021 | $650,000 | -44.2% | 25,200 | +15.6% | 0.14% | -51.0% |
Q4 2020 | $1,165,000 | +116400.0% | 21,800 | 0.0% | 0.29% | -13.5% |
Q3 2020 | $1,000 | -99.9% | 21,800 | +4.8% | 0.33% | +11.7% |
Q2 2020 | $1,008,000 | +34.8% | 20,800 | +17.5% | 0.30% | +10.8% |
Q1 2020 | $748,000 | +82.0% | 17,700 | +84.4% | 0.27% | +128.0% |
Q4 2019 | $411,000 | – | 9,600 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |